Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Non Operating Income (2016 - 2025)

Historic Non Operating Income for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $385022.9.

  • AC Immune's Non Operating Income rose 11888.91% to $385022.9 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 16347.88%. This contributed to the annual value of $1.7 million for FY2024, which is 34764.78% up from last year.
  • Latest data reveals that AC Immune reported Non Operating Income of $385022.9 as of Q3 2025, which was up 11888.91% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Non Operating Income registered a high of $4.8 million during Q3 2021, and its lowest value of -$2.2 million during Q2 2025.
  • In the last 5 years, AC Immune's Non Operating Income had a median value of $65950.9 in 2023 and averaged $263980.7.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 251088.97% in 2023, then skyrocketed by 373220.67% in 2024.
  • Quarter analysis of 5 years shows AC Immune's Non Operating Income stood at $1.6 million in 2021, then plummeted by 103.16% to -$51901.1 in 2022, then plummeted by 2510.89% to -$1.4 million in 2023, then soared by 337.89% to $3.2 million in 2024, then plummeted by 88.06% to $385022.9 in 2025.
  • Its last three reported values are $385022.9 in Q3 2025, -$2.2 million for Q2 2025, and $379277.4 during Q1 2025.